These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24661107)

  • 21. Bioabsorbable membrane and bioactive glass in the treatment of intrabony defects in patients with generalized aggressive periodontitis: results of a 5-year clinical and radiological study.
    Mengel R; Schreiber D; Flores-de-Jacoby L
    J Periodontol; 2006 Oct; 77(10):1781-7. PubMed ID: 17032123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A reentry study on the use of bovine porous bone mineral, GTR, and platelet-rich plasma in the regenerative treatment of intrabony defects in humans.
    Camargo PM; Lekovic V; Weinlaender M; Vasilic N; Madzarevic M; Kenney EB
    Int J Periodontics Restorative Dent; 2005 Feb; 25(1):49-59. PubMed ID: 15736778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of enamel matrix proteins and bioabsorbable membranes in the treatment of intrabony periodontal defects. A split-mouth study.
    Sculean A; Donos N; Blaes A; Lauermann M; Reich E; Brecx M
    J Periodontol; 1999 Mar; 70(3):255-62. PubMed ID: 10225541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioabsorbable membrane and bioactive glass in the treatment of intrabony defects in patients with generalized aggressive periodontitis: results of a 12-month clinical and radiological study.
    Mengel R; Soffner M; Flores-de-Jacoby L
    J Periodontol; 2003 Jun; 74(6):899-908. PubMed ID: 12887004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Five-year results of a prospective, randomized, controlled study evaluating treatment of intra-bony defects with a natural bone mineral and GTR.
    Sculean A; Schwarz F; Chiantella GC; Donos N; Arweiler NB; Brecx M; Becker J
    J Clin Periodontol; 2007 Jan; 34(1):72-7. PubMed ID: 17243997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of intrabony defects with an enamel matrix protein derivative or bioabsorbable membrane: an 8-year follow-up split-mouth study.
    Sculean A; Schwarz F; Miliauskaite A; Kiss A; Arweiler N; Becker J; Brecx M
    J Periodontol; 2006 Nov; 77(11):1879-86. PubMed ID: 17076614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of intrabony defects with enamel matrix proteins or barrier membranes: results from a multicenter practice-based clinical trial.
    Sanz M; Tonetti MS; Zabalegui I; Sicilia A; Blanco J; Rebelo H; Rasperini G; Merli M; Cortellini P; Suvan JE
    J Periodontol; 2004 May; 75(5):726-33. PubMed ID: 15212355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical outcomes following treatment of human intrabony defects with GTR/bone replacement material or access flap alone. A multicenter randomized controlled clinical trial.
    Tonetti MS; Cortellini P; Lang NP; Suvan JE; Adriaens P; Dubravec D; Fonzar A; Fourmousis I; Rasperini G; Rossi R; Silvestri M; Topoll H; Wallkamm B; Zybutz M
    J Clin Periodontol; 2004 Sep; 31(9):770-6. PubMed ID: 15312100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of pretreatment clinical parameters on bioactive glass implantation in intrabony periodontal defects.
    Park JS; Suh JJ; Choi SH; Moon IS; Cho KS; Kim CK; Chai JK
    J Periodontol; 2001 Jun; 72(6):730-40. PubMed ID: 11453234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of a collagen membrane with and without bone grafts in treating periodontal intrabony defects.
    Chen CC; Wang HL; Smith F; Glickman GN; Shyr Y; O'Neal RB
    J Periodontol; 1995 Oct; 66(10):838-47. PubMed ID: 8537865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GTR with three different types of membranes in the treatment of intrabony periodontal defects: three-year results in sixty consecutive cases.
    Windisch P; Sculean A; Gera I
    J Long Term Eff Med Implants; 1999; 9(3):235-46. PubMed ID: 10847965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of intrabony defects by different surgical procedures. A literature review.
    Laurell L; Gottlow J; Zybutz M; Persson R
    J Periodontol; 1998 Mar; 69(3):303-13. PubMed ID: 9579616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of intrabony defects with enamel matrix proteins or bioabsorbable membranes. A 4-year follow-up split-mouth study.
    Sculean A; Donos N; Miliauskaite A; Arweiler N; Brecx M
    J Periodontol; 2001 Dec; 72(12):1695-701. PubMed ID: 11811505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the effectiveness of enamel matrix derivative, bone grafts, and membrane in the treatment of mandibular Class II furcation defects.
    Jaiswal R; Deo V
    Int J Periodontics Restorative Dent; 2013; 33(2):e58-64. PubMed ID: 23484181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guided tissue regeneration in smokers: effect of aggressive anti-infective therapy in Class II furcation defects.
    Machtei EE; Oettinger-Barak O; Peled M
    J Periodontol; 2003 May; 74(5):579-84. PubMed ID: 12816288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A surgical reentry study on the influence of platelet-rich plasma in enhancing the regenerative effects of bovine porous bone mineral and guided tissue regeneration in the treatment of intrabony defects in humans.
    Camargo PM; Lekovic V; Weinlaender M; Divnic-Resnik T; Pavlovic M; Kenney EB
    J Periodontol; 2009 Jun; 80(6):915-23. PubMed ID: 19485821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of platelet-rich plasma on the healing of intrabony defects treated with an anorganic bovine bone mineral: a pilot study.
    Döri F; Kovács V; Arweiler NB; Huszár T; Gera I; Nikolidakis D; Sculean A
    J Periodontol; 2009 Oct; 80(10):1599-605. PubMed ID: 19792848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and histologic evaluation of a granular bovine bone biomaterial used as an adjunct to GTR with a bioresorbable bovine pericardium collagen membrane in the treatment of intrabony defects.
    Stavropoulos A; Chiantella G; Costa D; Steigmann M; Windisch P; Sculean A
    J Periodontol; 2011 Mar; 82(3):462-70. PubMed ID: 20932158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Root coverage stability of the subepithelial connective tissue graft and guided tissue regeneration: a 30-month follow-up clinical trial.
    Rosetti EP; Marcantonio E; Zuza EP; Marcantonio RA
    J Dent; 2013 Feb; 41(2):114-20. PubMed ID: 22652007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term results of guided tissue regeneration therapy with non-resorbable and bioabsorbable barriers. IV. A case series of infrabony defects after 10 years.
    Pretzl B; Kim TS; Holle R; Eickholz P
    J Periodontol; 2008 Aug; 79(8):1491-9. PubMed ID: 18673000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.